CRL cites WuXi synergies, client support to woo investors
CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up investor support.
CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up investor support.
ATMI Lifesciences has introduced 2D and 3D single-use bioprocess vessels (BPV) which reduce risk and cut costs.
Encap has announced its DuoCap capsule delivery system has been granted US and European patents that strengthen the firm’s portfolio in the delivery of pharmaceutical active agents that require controlled release.
Bosch Packaging has identified Asia as a key engine for future growth as its chief announced its international presence had helped the firm to “stand our ground in the global market place” during a tough 2009.
M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes a look at M&A processes, pitfalls and keys to success.
Mylan are to acquire Bioniche Pharma’s global injectable pharmaceuticals business for $550m (€430m) in a deal that gives Mylan a significant foothold in meeting product and therapeutic gaps in the US injectables market.
Applied Clinical Intelligence (ACI) has launched iCommittees to provide a platform to support sponsors’ needs for clinical endpoint adjudication and data monitoring committees (DMC).
Italy-based NerPharMa has signed a five-year deal to manufacture pixantrone for Cell Therapeutics (CTI).